DSS, Inc. (NYSEAMERICAN:DSS – Get Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 34,400 shares, a growth of 160.6% from the December 15th total of 13,200 shares. Based on an average daily volume of 38,500 shares, the days-to-cover ratio is currently 0.9 days. Approximately 1.9% of the company’s shares are sold short.
Insider Activity at DSS
In other DSS news, Director Heng Fai Ambrose Chan bought 205,149 shares of the business’s stock in a transaction on Tuesday, December 10th. The stock was bought at an average price of $0.97 per share, with a total value of $198,994.53. Following the completion of the purchase, the director now directly owns 1,184,475 shares in the company, valued at $1,148,940.75. The trade was a 20.95 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 59.30% of the stock is currently owned by insiders.
Institutional Investors Weigh In On DSS
An institutional investor recently bought a new position in DSS stock. Ferguson Wellman Capital Management Inc. bought a new position in shares of DSS, Inc. (NYSEAMERICAN:DSS – Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 25,501 shares of the business services provider’s stock, valued at approximately $32,000. Ferguson Wellman Capital Management Inc. owned approximately 0.36% of DSS at the end of the most recent quarter. Institutional investors own 53.33% of the company’s stock.
DSS Stock Down 5.0 %
DSS Company Profile
DSS, Inc operates in the product packaging, biotechnology, commercial lending, securities and investment management, alternative trading, and direct marketing businesses. It manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products.
Featured Stories
- Five stocks we like better than DSS
- How to Calculate Options Profits
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
- Trading Halts Explained
- Vertex’s Pain Drug: Big Pharma’s Next Major Success?
- What Are Trending Stocks? Trending Stocks Explained
- D-Wave’s Stock Springs Back in the Quantum Computing Race
Receive News & Ratings for DSS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DSS and related companies with MarketBeat.com's FREE daily email newsletter.